ATE353332T1 - Neuer, für die therapie geeigneter ligand für nikotinische acetylcholinrezeptoren - Google Patents

Neuer, für die therapie geeigneter ligand für nikotinische acetylcholinrezeptoren

Info

Publication number
ATE353332T1
ATE353332T1 AT02731063T AT02731063T ATE353332T1 AT E353332 T1 ATE353332 T1 AT E353332T1 AT 02731063 T AT02731063 T AT 02731063T AT 02731063 T AT02731063 T AT 02731063T AT E353332 T1 ATE353332 T1 AT E353332T1
Authority
AT
Austria
Prior art keywords
nicotinic acetylcholine
acetylcholine receptors
suitable ligand
new therapy
therapy
Prior art date
Application number
AT02731063T
Other languages
German (de)
English (en)
Inventor
Eifion Phillips
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE353332T1 publication Critical patent/ATE353332T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT02731063T 2001-06-01 2002-05-29 Neuer, für die therapie geeigneter ligand für nikotinische acetylcholinrezeptoren ATE353332T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29520601P 2001-06-01 2001-06-01

Publications (1)

Publication Number Publication Date
ATE353332T1 true ATE353332T1 (de) 2007-02-15

Family

ID=23136711

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02731063T ATE353332T1 (de) 2001-06-01 2002-05-29 Neuer, für die therapie geeigneter ligand für nikotinische acetylcholinrezeptoren

Country Status (18)

Country Link
EP (1) EP1397366B1 (enExample)
JP (1) JP2004532877A (enExample)
KR (1) KR20040003021A (enExample)
CN (1) CN1294136C (enExample)
AT (1) ATE353332T1 (enExample)
BR (1) BR0210075A (enExample)
CA (1) CA2455341A1 (enExample)
DE (1) DE60218032T2 (enExample)
DK (1) DK1397366T3 (enExample)
ES (1) ES2280538T3 (enExample)
IL (1) IL158735A0 (enExample)
MX (1) MXPA03010996A (enExample)
NO (1) NO20035333D0 (enExample)
NZ (1) NZ529426A (enExample)
PT (1) PT1397366E (enExample)
SI (1) SI1397366T1 (enExample)
WO (1) WO2002096912A1 (enExample)
ZA (1) ZA200308779B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10164139A1 (de) 2001-12-27 2003-07-10 Bayer Ag 2-Heteroarylcarbonsäureamide
EP1499618B1 (en) 2002-04-18 2010-10-13 AstraZeneca AB Furyl compounds
KR20040099446A (ko) * 2002-04-18 2004-11-26 아스트라제네카 아베 헤테로시클릭 화합물
CN1325499C (zh) 2002-04-18 2007-07-11 阿斯特拉曾尼卡有限公司 噻吩基化合物
EP1678183A1 (en) * 2003-10-21 2006-07-12 AstraZeneca AB Spirofuropyridine aryl derivatives
TW200813067A (en) * 2006-05-17 2008-03-16 Astrazeneca Ab Nicotinic acetylcholine receptor ligands
SA08290475B1 (ar) 2007-08-02 2013-06-22 Targacept Inc (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
ES2402084T3 (es) 2008-06-20 2013-04-26 Astrazeneca Ab Derivado de dibenzotiazepina y sus usos
TW201031664A (en) 2009-01-26 2010-09-01 Targacept Inc Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
CN103221411B (zh) 2010-05-17 2016-05-11 富瑞姆制药公司 (R)-7-氯-N-(奎宁环-3-基)苯并[b]噻吩-2-甲酰胺盐酸盐单水合物的晶型
GB201111704D0 (en) 2011-07-07 2011-08-24 Takeda Pharmaceutical Novel compounds
GB201111705D0 (en) 2011-07-07 2011-08-24 Takeda Pharmaceutical Compounds and their use
JO3115B1 (ar) 2011-08-22 2017-09-20 Takeda Pharmaceuticals Co مركبات بيريدازينون واستخدامها كمثبطات daao
CA2872005A1 (en) 2012-05-08 2013-11-14 Forum Pharmaceuticals, Inc. Methods of maintaining, treating or improving cognitive function
GB201209587D0 (en) 2012-05-30 2012-07-11 Takeda Pharmaceutical Therapeutic compounds
ES2694299T3 (es) 2013-02-07 2018-12-19 Heptares Therapeutics Limited Carboxilatos de piperidin-1-ilo y azepin-1-ilo como agonistas del receptor muscarínico M4
EA029430B1 (ru) 2013-06-21 2018-03-30 Такеда Фармасьютикл Компани Лимитед Производные 1-сульфонилпиперидина в качестве модуляторов рецепторов прокинетицина
GB201314286D0 (en) 2013-08-08 2013-09-25 Takeda Pharmaceutical Therapeutic Compounds
GB201318222D0 (en) 2013-10-15 2013-11-27 Takeda Pharmaceutical Novel compounds
GB201320905D0 (en) 2013-11-27 2014-01-08 Takeda Pharmaceutical Therapeutic compounds
TW201613864A (en) 2014-02-20 2016-04-16 Takeda Pharmaceutical Novel compounds
GB201616839D0 (en) 2016-10-04 2016-11-16 Takeda Pharmaceutical Company Limited Therapeutic compounds
GB201619514D0 (en) 2016-11-18 2017-01-04 Takeda Pharmaceuticals Co Novel compounds
JP2021138648A (ja) 2020-03-04 2021-09-16 武田薬品工業株式会社 経口固形製剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU744368B2 (en) * 1997-05-30 2002-02-21 Neurosearch A/S Spiro-quinuclidine derivatives, their preparation and use
AR013184A1 (es) * 1997-07-18 2000-12-13 Astrazeneca Ab Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis
SE9900100D0 (sv) * 1999-01-15 1999-01-15 Astra Ab New compounds

Also Published As

Publication number Publication date
EP1397366B1 (en) 2007-02-07
ZA200308779B (en) 2005-02-11
JP2004532877A (ja) 2004-10-28
EP1397366A1 (en) 2004-03-17
NO20035333D0 (no) 2003-11-28
BR0210075A (pt) 2004-08-17
KR20040003021A (ko) 2004-01-07
HK1063787A1 (en) 2005-01-14
DE60218032T2 (de) 2007-08-16
IL158735A0 (en) 2004-05-12
DE60218032D1 (de) 2007-03-22
NZ529426A (en) 2005-07-29
CN1294136C (zh) 2007-01-10
DK1397366T3 (da) 2007-05-07
CA2455341A1 (en) 2002-12-05
MXPA03010996A (es) 2004-02-27
PT1397366E (pt) 2007-04-30
SI1397366T1 (sl) 2007-06-30
CN1512995A (zh) 2004-07-14
WO2002096912A1 (en) 2002-12-05
ES2280538T3 (es) 2007-09-16

Similar Documents

Publication Publication Date Title
ATE353332T1 (de) Neuer, für die therapie geeigneter ligand für nikotinische acetylcholinrezeptoren
DE60325234D1 (de) Biaryldiazabicycloalkanamide als nicotinische acetylcholinagonisten
CY1109063T1 (el) Υποκατεστημενες 2-θειο-3,5-δικυανο-4-φαινυλο-6-αμινοπυριδινες και χρηση αυτων
DE60142355D1 (de) Piperazinylpyrazinverbindungen als agonisten oder antagonisten am serotonin-5ht-2-rezeptor
CY1113578T1 (el) 2,3-διυδρο-6-νιτροϊμιδαζο 2,1 -b-οξαζολια
DE60225341D1 (de) Neue 1,2,4-triazolverbindung
DE60210785D1 (de) Fungizide mischung, die arylamidinderivate enthält
EA200600620A1 (ru) Набор для ингаляции с ингаляционным порошком, содержащим тиотропий
IS5888A (is) Efnameðferð við krabbameini með asetýldínalíni blönduðu gemsítabíni, kapesítabíni eða sisplatíni
NO20023840D0 (no) Reversert flyt stator ventilasjonssystem for superledende synkron maskin
CY1106579T1 (el) Μεθοδος για την παρασκευη συμπλοκων 1,2-διαμινοκυκλοεξανιου-δισθενους πλατινης
DE60317675D1 (de) KRYSTALLINE 2,5-DIONE-3-(1-METHYL-1H-INDOL-3-YL)-4-i1-(PYRIDIN-2-YLMETHYL)PIPERIDIN-4-YL -1H-INDOL-3-YL -1H-PYRROLE MONO-HYDROCHLORIDE
EP1568432A3 (en) Miter saw
TR200402546T4 (tr) Taksan türevleri hazırlamak için işlem.
AP1633A (en) Compositions of cupric salts and their use for the control of phytopathogenic fungi.
TR200700266T1 (tr) Bir soğutucu.
AR027349A1 (es) Derivados de amidas heterociclicas
MXPA05012297A (es) Indazol que tiene actividad analgesica.
TR200603433T1 (tr) Bir soğutucu
ATE455779T1 (de) Bis-(n,n'-bis-(2-haloethyl)amino)-phosphoramida e als anti-tumormittel
PT102851A (pt) Mesa para maquina de costura
AR033261A1 (es) Antagonistas de nmda para el tratamiento de enfermedades adictivas
DE60331100D1 (de) Übergangsmetallkomplex mit diphosphinverbindung als ligand
DE60132499D1 (de) Tuftinggarnzuführvorrichtung
MXPA03003478A (es) Compuestos heterociclicos 2-sustituidos y su uso para tratar resistencia a multiples farmacos.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1397366

Country of ref document: EP

REN Ceased due to non-payment of the annual fee